
‘Tis the Season…
Key Points In today’s Recommendations for Industry, we discuss current seasonal illnesses and what businesses should be doing. Read more below. Yesterday, with the increased
Key Points In today’s Recommendations for Industry, we discuss current seasonal illnesses and what businesses should be doing. Read more below. Yesterday, with the increased
In today’s Recommendations for Industry, we provide updates on the vaccine mandate and boosters. Read more below. Canada’s government announced last Thursday that it has
In today’s Recommendations for Industry, we discuss the risk matrix and the current decline of COVID-19 coinciding with the OSHA vaccination/testing standards. Read more below.
body.kc-css-system .kc-css-3780867{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-1384976 .section-title h2,body.kc-css-system .kc-css-1384976 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-1384976 .section-title h2 span,body.kc-css-system .kc-css-1384976 .title_tx h2 span,body.kc-css-system .kc-css-1384976 .em-icon i{color: #973333;}body.kc-css-system .kc-css-804196
body.kc-css-system .kc-css-3813686{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-1709976 .section-title h2,body.kc-css-system .kc-css-1709976 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-1709976 .section-title h2 span,body.kc-css-system .kc-css-1709976 .title_tx h2 span,body.kc-css-system .kc-css-1709976 .em-icon i{color: #973333;}body.kc-css-system .kc-css-1353280
body.kc-css-system .kc-css-4223533{margin-top: 30px;padding-top: 38px;}body.kc-css-system .kc-css-133719 .section-title h2,body.kc-css-system .kc-css-133719 .title_tx h2{font-size: 1.4em;padding-top: 27px;}body.kc-css-system .kc-css-133719 .section-title h2 span,body.kc-css-system .kc-css-133719 .title_tx h2 span,body.kc-css-system .kc-css-133719 .em-icon i{color: #973333;}body.kc-css-system .kc-css-647666
J&J Vaccine Review (and authorization?) Coming Today Key Points: In today’s Recommendations for Industry, we discuss the J&J vaccine being reviewed for EUA by FDA